Publicaciones en colaboración con investigadores/as de Centre Hospitalier Universitaire de Poitiers (2)

2022

  1. Melphalan flufenamide for relapsed/refractory multiple myeloma

    Drugs of today (Barcelona, Spain : 1998), Vol. 58, Núm. 8, pp. 407-423

2018

  1. Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trials

    Hematological Oncology, Vol. 36, Núm. 2, pp. 463-470